Abstract
Background: Breast cancer considerably affects both developed and developing nations globally, it has been the focus of several studies. Lymphedema in breast cancer survivors is a more prevalent condition that healthcare providers often fail to completely comprehend. About five in one women who have undergone breast cancer surgery acquires Breast Cancer Related Lymphedema (BCRL). Lymphedema is a chronic and debilitating disease that that can develop as a consequence of breast cancer treatment. It can have disastrous impacts on a patient's quality of life associated with lymphedema. In general, it is underreported and undertreated. The aim of this reviews study is to determine the effectiveness of CDT on reducing the occurrence of lymphedema in breast cancer patients. Methodology: For these studies literature review, databases PubMed, Google Scholar and science direct were employed. Articles published from 2019-2023, and with the full English text met the inclusion criteria. Articles published prior to 2019 and articles having an incorrect abstract were excluded. Results: CDT has been shown to be useful in reducing the symptoms associated with BCRL. It proved that exercise is safe, in addition to it is important to continue exercise in daily life. The functional status of the patients also showed a noticeable improvement. Conclusion: In patients with BCRL, CDT improves upper extremity functioning and quality of life. Contributing factors include the decrease in volume of lymphedema, aching and heaviness, and an increase in shoulder movement. CDT is a promising therapeutic modality for the lymphedema.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call